0001209191-22-028324.txt : 20220511 0001209191-22-028324.hdr.sgml : 20220511 20220511163436 ACCESSION NUMBER: 0001209191-22-028324 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220510 FILED AS OF DATE: 20220511 DATE AS OF CHANGE: 20220511 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CALSADA CRISPINA CENTRAL INDEX KEY: 0001606833 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35670 FILM NUMBER: 22914319 MAIL ADDRESS: STREET 1: C/O AMBRX, INC. STREET 2: 10975 N. TORREY PINES RD. CITY: LA JOLLA STATE: CA ZIP: 92037 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Regulus Therapeutics Inc. CENTRAL INDEX KEY: 0001505512 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 264738379 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4224 CAMPUS POINT COURT STREET 2: SUITE 210 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-202-6300 MAIL ADDRESS: STREET 1: 4224 CAMPUS POINT COURT STREET 2: SUITE 210 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-05-10 0 0001505512 Regulus Therapeutics Inc. RGLS 0001606833 CALSADA CRISPINA C/O REGULUS THERAPEUTICS 4224 CAMPUS POINT COURT #210 SAN DIEGO CA 92121 0 1 0 0 Chief Financial Officer Stock Option (Right to Buy) 1.31 2022-05-10 4 A 0 50000 0.00 A 2030-01-20 Common Stock 50000 50000 D The option vests only upon achievement of a performance-based milestone. The performance criteria were met, resulting in vesting of the option. Upon achievement of the milestone and verification of same by the Company's Compensation Committee, one hundred percent of the shares immediately vested. Christopher Aker, Attorney in Fact 2022-05-11